Novo Nordisk today announced the presentation of 34 abstracts highlighting the breadth of its portfolio at the upcoming 84th Scientific Sessions of the American Diabetes Association (ADA). The
confere... Stay informed with the latest.
(Editor-in-Chief: Spotlight)
